|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61P 35/00 | |||
| G01N 33/53 | |||
| C07K 16/24 |
| (11) | Number of the document | 2332575 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10179775.1 |
| Date of filing the European patent application | 2004-12-23 | |
| (97) | Date of publication of the European application | 2011-06-15 |
| (45) | Date of publication and mention of the grant of the patent | 2014-11-12 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 532130 P | 2003-12-23 | US |
| (72) |
Fung, Sek Chung, US
Moyle, Matthew, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | Treatment of cancer with novel anti-IL 13 monoclonal antibodies |
| Treatment of cancer with novel anti-IL 13 monoclonal antibodies |